12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
12.5.2.30 DHS rekommandationer for KMT 2011.pdf - e-Dok
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Gale, R.P., Horowitz, M.M., Weiner, R.S., Ash, R.C., Atkinson, K., Babu, R., Dicke, K.A., Klein, J.P., Lowenberg,<br />
B., Reiffers, J., and et, a. Impact of cytogenetic abnormalities on outcome of bone marrow transplants in acute<br />
myelogenous leukemia in first remission. Bone Marrow Transplant., 16: 203-208, 1995.<br />
Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C,<br />
Maloney DG, Storb R. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic<br />
cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation<br />
comorbidities. Blood. 2004 Aug 15;104(4):961-8.<br />
Allogen <strong>KMT</strong> af primært kemoterapiresistent AML<br />
Greinix, H.T., Reiter, E., Keil, F., Fischer, G., Lechner, K., Dieckmann, K., Leitner, G., Schulenburg, A., Hoecker,<br />
P., Haas, O.A., Knoebl, P., Mannhalter, C., Fonatsch, C., Hinterberger, W., and Kalhs, P. Leukemia-free survival<br />
and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and<br />
unrelated donors. Bone Marrow Transplant, 21: 673-678, 1998.<br />
Chiang KY, Van Rhee F, Godder K, Bridges K, Adams S, Mehta J, Henslee-Downey PJ. Allogeneic bone<br />
marrow transplantation from partially mismatched related donors as therapy <strong>for</strong> primary induction failure acute<br />
myeloid leukemia. Bone Marrow Transplant. 2001 Mar;27(5):507-10.<br />
Singhal S, Powles R, Henslee-Downey PJ, Chiang KY, Treleaven J, Godder K, Kulkarni S, van Rhee F, Sirohi B,<br />
Pinkerton CR, Meller S, Mehta J. Allogeneic transplantation from HLA-matched sibling or partially HLAmismatched<br />
related donors <strong>for</strong> primary refractory acute leukemia. Bone Marrow Transplant. 2002 Feb;29(4):291-<br />
5.<br />
AML 1. CR prospektive undersøgelser<br />
Appelbaum, F.R., Fisher, L.D., and Thomas, E.D. Chemotherapy v marrow transplantation <strong>for</strong> adults with acute<br />
nonlymphocytic leukemia: a five-year follow-up. Blood, 72: 179-184, 1988.<br />
Burnett, A.K., Goldstone, A.H., Stevens, R.M., Hann, I.M., Rees, J.K., Gray, R.G., and Wheatley, K. Randomised<br />
comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy <strong>for</strong> acute myeloid<br />
leukaemia in first remission: results of MRC AML 10 trial. UK Medical Research Council Adult and Children's<br />
Leukaemia Working Parties. Lancet, 351: 700-708, 1998.<br />
Burnett AK, Wheatley K, Goldstone AH, Stevens RF, Hann IM, Rees JH, Harrison G; Medical Research Council<br />
Adult and Paediatric Working Parties. The value of allogeneic bone marrow transplant in patients with acute<br />
myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial.<br />
Br J Haematol. 2002 Aug;118(2):385-400.<br />
31
Change language